Vivo Opportunity Fund Holdings, L.P. - 30 Sep 2025 SCHEDULE 13G/A Report for Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share (SLNO)

Filing Manager
Vivo Opportunity Fund Holdings, L.P.
Reporting Manager
Vivo Opportunity Fund Holdings, L.P.
Security
Soleno Therapeutics, Inc. Common Stock, $0.001 par value per share
Symbol
SLNO
Shares outstanding
53,599,048 shares
Disclosed Ownership
2,251,160 shares
Ownership
4.2%
Form type
SCHEDULE 13G/A
Filing time
14 Nov 2025, 18:35:00 UTC
Date of event
30 Sep 2025
Previous filing
12 Aug 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Vivo Opportunity Fund Holdings, L.P. 4.2% 2,251,160 2,251,160 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity, LLC 4.2% 2,251,160 2,251,160 0 /s/ Kevin Dai Kevin Dai/Managing Member
Vivo Opportunity Cayman Fund, L.P. 0.1% 27,043 27,043 0 /s/ Kevin Dai Kevin Dai/Managing Member of Vivo Opportunity, LLC, General Partner
Vivo Opportunity Cayman, LLC 0.1% 27,043 27,043 0 /s/ Kevin Dai Kevin Dai/Managing Member